IDEXX Laboratories to Present at Two Institutional Investor Conferences
IDEXX Laboratories (NASDAQ: IDXX) will participate in two investor conferences in late February and early March 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
- Thursday, February 26, 9:55 am – 10:30 am EST – Mike Lane, Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology, and Andrew Emerson, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the virtual BofA Securities Animal Health Summit.
- Monday, March 2, 9:15 am – 9:45 am EST – Jay Mazelsky, President and Chief Executive Officer, will present at the 47th Annual Raymond James Institutional Investors Conference.
Live webcasts of the presentations will be available through links on the IDEXX website, www.idexx.com/investors. Archived editions of the presentations will be available via the same link.
About IDEXX Laboratories, Inc.
IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500™ Index. Headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20260212000714/en/
Investor Relations
investorrelations@idexx.com
Source: IDEXX Laboratories, Inc.